Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VORTIOXETINE HYDROBROMIDE Cause Decreased activity? 10 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Decreased activity have been filed in association with VORTIOXETINE HYDROBROMIDE (Trintellix). This represents 0.1% of all adverse event reports for VORTIOXETINE HYDROBROMIDE.

10
Reports of Decreased activity with VORTIOXETINE HYDROBROMIDE
0.1%
of all VORTIOXETINE HYDROBROMIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Decreased activity From VORTIOXETINE HYDROBROMIDE?

Of the 10 reports, 2 (20.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.

Is Decreased activity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VORTIOXETINE HYDROBROMIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does VORTIOXETINE HYDROBROMIDE Cause?

Nausea (2,062) Anxiety (861) Vomiting (811) Suicidal ideation (742) Headache (738) Fatigue (697) Drug ineffective (693) Pruritus (653) Insomnia (636) Feeling abnormal (620)

What Other Drugs Cause Decreased activity?

NIRAPARIB (586) SACUBITRIL\VALSARTAN (570) RUXOLITINIB (558) DUPILUMAB (231) LEVOTHYROXINE (201) TREPROSTINIL (195) PREDNISONE (193) ALBUTEROL (190) EMTRICITABINE\TENOFOVIR DISOPROXIL (186) TERIPARATIDE (156)

Which VORTIOXETINE HYDROBROMIDE Alternatives Have Lower Decreased activity Risk?

VORTIOXETINE HYDROBROMIDE vs VOSORITIDE VORTIOXETINE HYDROBROMIDE vs VOTRIENT VORTIOXETINE HYDROBROMIDE vs VOXELOTOR VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN VORTIOXETINE HYDROBROMIDE vs VX-950

Related Pages

VORTIOXETINE HYDROBROMIDE Full Profile All Decreased activity Reports All Drugs Causing Decreased activity VORTIOXETINE HYDROBROMIDE Demographics